This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $485,774
Clonal Hematopoiesis in Venous Thromboembolism: Advancing Precision in Risk Prediction and Treatment Outcomes
CIHR · 2026 · Co-investigator
- $19,728
Inflammation, clonal hematopoiesis, and venous thromboembolism among ethnic and racially underrepresented older adults
CIHR · 2024 · Principal investigator
Clonal Hematopoiesis in Venous Thromboembolism: Advancing Precision in Risk Prediction and Treatment Outcomes
Principal investigators: Xu, Yan; Carrier, Marc
Keywords: Clonal Hematopoiesis; Major Bleeding; Venous Thromboembolism
Inflammation, clonal hematopoiesis, and venous thromboembolism among ethnic and racially underrepresented older adults
Principal investigators: Xu, Yan; Carrier, Marc; Cénat, Jude Mary; Hsu, Amy T; Lettre, Guillaume
Keywords: Older Adults; Racial Disparity
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.